How Immunotherapy Has Changed the Continuum of Care in Hepatocellular Carcinoma

SIMPLE SUMMARY: HCC is a very aggressive disease and patients diagnosed in an advanced/metastatic setting obtain poor survival outcomes with standard treatments. In recent years, the introduction of immunotherapy strategies, such as immune checkpoint inhibitors as single agents and in combination wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Martini, Giulia, Ciardiello, Davide, Paragliola, Fernando, Nacca, Valeria, Santaniello, Walter, Urraro, Fabrizio, Stanzione, Maria, Niosi, Marco, Dallio, Marcello, Federico, Alessandro, Selvaggi, Francesco, Della Corte, Carminia Maria, Napolitano, Stefania, Ciardiello, Fortunato, Martinelli, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466991/
https://www.ncbi.nlm.nih.gov/pubmed/34572944
http://dx.doi.org/10.3390/cancers13184719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466991/
https://www.ncbi.nlm.nih.gov/pubmed/34572944
http://dx.doi.org/10.3390/cancers13184719

Ejemplares similares